UK DELIVERY £4.00 · FREE ON ORDERS OVER £60

RATED 4.7/5 ON TRUSTED SHOPS ·

Hifas da Terra Participates in the Microinmunomama R&D Project

MicroInmunomama

Equipo Editorial Hifas |

Hifas da Terra is participating in the final phase of the Microinmunomama R&D project, a collaborative research initiative involving the Galicia Sur Health Research Institute and the Leitat technology centre.

The project has received funding from the Spanish Ministry of Science and Innovation through the Challenges Collaboration Programme.

A collaborative research project

The participating organisations contribute complementary expertise in research, analytical methods, biotechnology and product development.

Hifas da Terra’s work within the project includes the research and analytical characterisation of mushroom-derived ingredients and food supplement formulations under controlled conditions.

The project also uses molecular and multi-omics methods to collect and analyse scientific data. Multi-omics is an approach that combines different types of biological data to support a more detailed analysis within a research protocol.

Research, analysis and product development

Participation in collaborative projects enables Hifas da Terra to expand its technical knowledge of mushroom-derived ingredients, formulation methods and analytical processes.

This work forms part of the company’s continuing commitment to research, technological development and collaboration with external scientific organisations.

Research is an ongoing process. Participation in a research project does not, by itself, demonstrate that a commercially available food supplement provides a particular health benefit.

Frequently asked questions

Answers to the most common questions

Los resultados de un ensayo clínico solo pueden considerarse evidencia cuando se publican en una revista con revisión por pares o constan en un registro público de ensayos. Conviene consultar esas fuentes antes de atribuir cualquier efecto a un producto.

Estudios observacionales en mujeres posmenopáusicas, como los de Fuhrman et al. (2014) y Goedert et al. (2015), describen asociaciones con el metabolismo de estrógenos y con el cáncer de mama, pero son estudios pequeños y no demuestran causalidad.

Un prebiótico es un sustrato utilizado selectivamente por microorganismos del huésped que confiere un beneficio para la salud (consenso ISAPP). Los β-glucanos de hongos se investigan como posibles prebióticos, pero la evidencia humana es limitada.

No hay evidencia que lo respalde: es una hipótesis en investigación. Además, la normativa de la UE no permite atribuir a un alimento propiedades de prevención o tratamiento de enfermedades.

References

Fuhrman, B. J., Feigelson, H. S., Flores, R., Gail, M. H., Xu, X., Ravel, J., & Goedert, J. J. (2014). Associations of the fecal microbiome with urinary estrogens and estrogen metabolites in postmenopausal women. The Journal of Clinical Endocrinology & Metabolism, 99(12), 4632–4640. https://doi.org/10.1210/jc.2014-2222

Gibson, G. R., et al. (2017). Expert consensus document: The International Scientific Association for Probiotics and Prebiotics (ISAPP) consensus statement on the definition and scope of prebiotics. Nature Reviews Gastroenterology & Hepatology, 14(8), 491–502. https://doi.org/10.1038/nrgastro.2017.75

Goedert, J. J., et al. (2015). Investigation of the association between the fecal microbiota and breast cancer in postmenopausal women: A population-based case-control pilot study. Journal of the National Cancer Institute, 107(8), Artículo djv147. https://doi.org/10.1093/jnci/djv147

PDQ Integrative, Alternative, and Complementary Therapies Editorial Board. (s. f.). Medicinal mushrooms (PDQ®): Health professional version. National Cancer Institute. https://pubmed.ncbi.nlm.nih.gov/27929633/

Reglamento (UE) n.º 1169/2011 del Parlamento Europeo y del Consejo, de 25 de octubre de 2011, sobre la información alimentaria facilitada al consumidor. Diario Oficial de la Unión Europea, L 304, 18–63. https://eur-lex.europa.eu/eli/reg/2011/1169/oj